Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by antitumor triazoloacridinone C-1305. - Publikacja - MOST Wiedzy

Twoje konto

zaloguj

Wyszukiwarka

Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by antitumor triazoloacridinone C-1305.

Abstrakt

5-Dimethylaminopropylamino-8-hydroxytriazoloacridinone, C-1305, is a promising antitumor therapeutic agent with high activity against several experimental tumors. It was determined to be a potent and selective inhibitor of liver microsomal and human recombinant cytochrome P450 (CYP) 1A2 and 3A4 isoenzymes. Therefore, C-1305 might modulate the effectiveness of other drugs used in multidrug therapy. The objective of this study was to investigate the mechanism of the observed C-1305- mediated inactivation of CYP1A2 and CYP3A4. Our findings indicated that C-1305 produced a time- and concentration-dependent decrease in 7-ethoxycoumarin O-deethylation (CYP1A2, KI = 10.8 ± 2.14 mM) and testosterone 6bhydroxylation (CYP3A4, KI = 9.1 ± 2.82 mM). The inactivation required the presence of NADPH, was unaffected by a nucleophilic trapping agent (glutathione) and a reactive oxygen species scavenger (catalase), attenuated by a CYP-specific substrate (7-ethoxycoumarin or testosterone), and was not reversed by potassium ferricyanide. The estimated partition ratios of 1086 and 197 were calculated for the inactivation of CYP1A2 and CYP3A4, respectively. In conclusion, C-1305 inhibited human recombinant CYP1A2 and CYP3A4 isoenzymes by mechanism-based inactivation. The obtained knowledge about specific interactions between C-1305 and/or its metabolites, and CYP isoforms would be useful for predicting the possible drug–drug interactions in potent multidrug therapy.

Cytowania

  • 6

    CrossRef

  • 0

    Web of Science

  • 6

    Scopus

Autorzy (3)

Cytuj jako

Pełna treść

pobierz publikację
pobrano 11 razy
Wersja publikacji
Accepted albo Published Version
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3109/00498254.2016.1147623
Licencja
Creative Commons: CC-BY-NC otwiera się w nowej karcie

Słowa kluczowe

Informacje szczegółowe

Kategoria:
Publikacja w czasopiśmie
Typ:
artykuł w czasopiśmie wyróżnionym w JCR
Opublikowano w:
XENOBIOTICA nr 46, strony 1056 - 1065,
ISSN: 0049-8254
Język:
angielski
Rok wydania:
2016
Opis bibliograficzny:
Potęga A., Fedejko-Kap, B., Mazerska Z.: Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by antitumor triazoloacridinone C-1305.// XENOBIOTICA. -Vol. 46, nr. 12 (2016), s.1056-1065
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3109/00498254.2016.1147623
Weryfikacja:
Politechnika Gdańska

wyświetlono 107 razy

Publikacje, które mogą cię zainteresować

Imidazoacridinone antitumor agent C-1311 as a selective mechanism- based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes.

2016

Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7

2018

Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs’ Cytotoxicity, Metabolism and Cellular Response

2020

Metabolism of antitumour agent 1-nitroacridine derivative, C-1748 in pancreatic cancer cell lines

2015
Meta Tagi